LAS VEGAS, Dec. 16, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging biotechnology company focused on developing cell-based therapies for diabetes ...
LAS VEGAS, Sept. 18, 2025 /PRNewswire/ -- Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company"), a Nevada-based corporation, and Austrianova (SGAustria Pte. Ltd.), a Singapore-based ...
OncoNano Medicine, Inc. ("OncoNano") today announced a research collaboration with Gilead Sciences, Inc. (Nasdaq: GILD) ...
The gene therapy market is surging toward $36.55 billion by 2032, powered by rising demand for curative treatments that target genetic diseases at their source([1]) . The FDA approved three ...
A company offering a flexible encapsulation technology that can transport cells without specialist cryopreservation is expanding from animal to human health. Likarda, which was spun out of the ...
Techceuticals has announced its 2026 training schedule for solid dosage manufacturing, featuring a full lineup of two-day, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback